<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:03:54Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5324688" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5324688</identifier><datestamp>2017-03-14</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="letter">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Br J Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Br. J. Dermatol</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1365-2133</journal-id>
      <journal-id journal-id-type="publisher-id">BJD</journal-id>
      <journal-title-group>
        <journal-title>The British Journal of Dermatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0007-0963</issn>
      <issn pub-type="epub">1365-2133</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5324688</article-id>
      <article-id pub-id-type="pmcid">PMC5324688</article-id>
      <article-id pub-id-type="pmc-uid">5324688</article-id>
      <article-id pub-id-type="pmid">27479915</article-id>
      <article-id pub-id-type="doi">10.1111/bjd.14914</article-id>
      <article-id pub-id-type="publisher-id">BJD14914</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Letter to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
          <subj-group subj-group-type="heading">
            <subject>Letters to the Editor</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in <italic><styled-content style="fixed-case">POGLUT</styled-content>1</italic> in GalliâGalli/DowlingâDegos disease</article-title>
      </title-group>
      <contrib-group>
        <contrib id="bjd14914-cr-0001" contrib-type="author">
          <name>
            <surname>Wilson</surname>
            <given-names>N.J.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0002" contrib-type="author">
          <name>
            <surname>Cole</surname>
            <given-names>C.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="bjd14914-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0003" contrib-type="author">
          <name>
            <surname>Kroboth</surname>
            <given-names>K.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0004" contrib-type="author">
          <name>
            <surname>Hunter</surname>
            <given-names>W.N.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0005" contrib-type="author">
          <name>
            <surname>Mann</surname>
            <given-names>J.A.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0004">
<sup>4</sup>
</xref>
          <xref ref-type="aff" rid="bjd14914-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0006" contrib-type="author">
          <name>
            <surname>McLean</surname>
            <given-names>W.H.I.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0007" contrib-type="author">
          <name>
            <surname>Kernland Lang</surname>
            <given-names>K.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0008" contrib-type="author">
          <name>
            <surname>Beltraminelli</surname>
            <given-names>H.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0009" contrib-type="author">
          <name>
            <surname>Sabroe</surname>
            <given-names>R.A.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0010" contrib-type="author">
          <name>
            <surname>Tiffin</surname>
            <given-names>N.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0008">
<sup>8</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0011" contrib-type="author">
          <name>
            <surname>Sobey</surname>
            <given-names>G.J.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0009">
<sup>9</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0012" contrib-type="author">
          <name>
            <surname>Borradori</surname>
            <given-names>L.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0013" contrib-type="author">
          <name>
            <surname>Simpson</surname>
            <given-names>E.</given-names>
          </name>
          <xref ref-type="aff" rid="bjd14914-aff-0004">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="bjd14914-cr-0014" contrib-type="author" corresp="yes">
          <name>
            <surname>Smith</surname>
            <given-names>F.J.D.</given-names>
          </name>
          <address>
            <email>frances.smith@pachyonychia.org</email>
          </address>
          <xref ref-type="aff" rid="bjd14914-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="bjd14914-aff-0010">
<sup>10</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="bjd14914-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Dermatology and Genetic Medicine</named-content>
        <named-content content-type="organisation-division">Division of Biological Chemistry and Drug Discovery</named-content>
        <named-content content-type="organisation-division">School of Life Sciences</named-content>
        <institution>University of Dundee</institution>
        <named-content content-type="city">Dundee</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd14914-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Division of Computational Biology</named-content>
        <named-content content-type="organisation-division">School of Life Sciences</named-content>
        <institution>University of Dundee</institution>
        <named-content content-type="city">Dundee</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd14914-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <named-content content-type="organisation-division">Division of Biological Chemistry and Drug Discovery</named-content>
        <named-content content-type="organisation-division">School of Life Sciences</named-content>
        <institution>University of Dundee</institution>
        <named-content content-type="city">Dundee</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd14914-aff-0004">
        <label>
          <sup>4</sup>
        </label>
        <named-content content-type="organisation-division">Department of Dermatology</named-content>
        <institution>Oregon Health &amp; Sciences University</institution>
        <named-content content-type="city">Portland</named-content>
        <named-content content-type="country-part">OR</named-content>
        <country country="US">U.S.A.</country>
      </aff>
      <aff id="bjd14914-aff-0005">
        <label>
          <sup>5</sup>
        </label>
        <named-content content-type="organisation-division">Division of Dermatology</named-content>
        <institution>DartmouthâHitchcock Medical Center</institution>
        <named-content content-type="city">Lebanon</named-content>
        <named-content content-type="country-part">NH</named-content>
        <country country="US">U.S.A.</country>
      </aff>
      <aff id="bjd14914-aff-0006">
        <label>
          <sup>6</sup>
        </label>
        <named-content content-type="organisation-division">Department of Dermatology</named-content>
        <institution>University HospitalâInselspital Bern</institution>
        <institution>University of Bern</institution>
        <named-content content-type="city">Bern</named-content>
        <country country="CH">Switzerland</country>
      </aff>
      <aff id="bjd14914-aff-0007">
        <label>
          <sup>7</sup>
        </label>
        <named-content content-type="organisation-division">Department of Dermatology</named-content>
        <institution>Royal Hallamshire Hospital</institution>
        <named-content content-type="city">Sheffield</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd14914-aff-0008">
        <label>
          <sup>8</sup>
        </label>
        <named-content content-type="organisation-division">Department of Histopathology</named-content>
        <institution>Royal Hallamshire Hospital</institution>
        <named-content content-type="city">Sheffield</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd14914-aff-0009">
        <label>
          <sup>9</sup>
        </label>
        <named-content content-type="organisation-division">Department of Clinical Genetics</named-content>
        <institution>Sheffield Children's Hospital</institution>
        <named-content content-type="city">Sheffield</named-content>
        <country country="GB">U.K.</country>
      </aff>
      <aff id="bjd14914-aff-0010">
        <label>
          <sup>10</sup>
        </label>
        <institution>Pachyonychia Congenita Project</institution>
        <named-content content-type="city">Salt Lake City</named-content>
        <named-content content-type="country-part">UT</named-content>
        <country country="US">U.S.A.</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>
Correspondence: Frances J.D. Smith.<break/>
Eâmail: <email>frances.smith@pachyonychia.org</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2017</year>
      </pub-date>
      <volume>176</volume>
      <issue>1</issue>
      <issue-id pub-id-type="doi">10.1111/bjd.2017.176.issue-1</issue-id>
      <fpage>270</fpage>
      <lpage>274</lpage>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 British Association of Dermatologists <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. <italic>British Journal of Dermatology</italic> published by John Wiley &amp; Sons Ltd on behalf of British Association of Dermatologists.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:BJD-176-270.pdf"/>
      <funding-group>
        <award-group>
          <funding-source>Pachyonychia Congenita Project</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Wellcome Trust
</funding-source>
          <award-id>098439/Z/12/Z</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="0"/>
        <page-count count="5"/>
        <word-count count="1894"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>bjd14914</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>January 2017</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.7 mode:remove_FC converted:24.02.2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <fn-group id="bjd14914-ntgp-0001">
        <fn id="bjd14914-note-1001">
          <p>Funding sources: F.J.D.S. and N.J.W. were supported by a grant from the Pachyonychia Congenita Project (to F.J.D.S.; <ext-link ext-link-type="uri" xlink:href="http://www.pachyonychia.org">www.pachyonychia.org</ext-link>). The Centre for Dermatology and Genetic Medicine at the University of Dundee is supported by a Wellcome Trust Strategic Award (098439/Z/12/Z to W.H.I.M.).</p>
        </fn>
        <fn id="bjd14914-note-1002">
          <p>Conflicts of interest: none declared.</p>
        </fn>
      </fn-group>
    </notes>
  </front>
  <body>
    <p>
<sc>dear editor</sc>, The group of reticulate pigmentary disorders includes the rare autosomal dominant DowlingâDegos disease (DDD) and GalliâGalli disease (GGD; OMIM 179850, 615327 and 615696).<xref rid="bjd14914-bib-0001" ref-type="ref">1</xref> In light of substantial clinical, histological and mutational overlap between GGD and DDD, they are considered to belong to the same entity.<xref rid="bjd14914-bib-0002" ref-type="ref">2</xref>, <xref rid="bjd14914-bib-0003" ref-type="ref">3</xref> Mutations in <italic>KRT5</italic> (encoding keratin 5) have been associated with GGD/DDD since 2006.<xref rid="bjd14914-bib-0002" ref-type="ref">2</xref>, <xref rid="bjd14914-bib-0003" ref-type="ref">3</xref>, <xref rid="bjd14914-bib-0004" ref-type="ref">4</xref>, <xref rid="bjd14914-bib-0005" ref-type="ref">5</xref> With the development of wholeâexome sequencing, mutations in <italic>POFUT1</italic> (encoding protein <italic>O</italic>âfucosyltransferase 1)<xref rid="bjd14914-bib-0006" ref-type="ref">6</xref>, <xref rid="bjd14914-bib-0007" ref-type="ref">7</xref> and <italic>POGLUT1</italic> (encoding protein <italic>O</italic>âglucosyltransferase 1)<xref rid="bjd14914-bib-0008" ref-type="ref">8</xref> have been shown to underlie some cases of GGD/DDD. We report mutations in <italic>POGLUT1</italic> in three families of European ancestry.</p>
    <p>In family 1 the mother presented, aged 75 years, with a 40âyear history of reticulate hyperpigmented scaling plaques on the neck, lateral proximal arms, proximal legs and popliteal fossae (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>a, b). Light microscopy revealed epidermal acanthosis, hypergranulosis and hyperkeratosis with parakeratosis and suprabasilar acantholysis (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>c). Direct DNA sequencing of <italic>KRT5</italic> was negative for mutations. A wholeâexome sequencing approach was taken using DNA from the affected mother (Appendix S1 and Table S1; see Supporting Information). During this time mutations were reported in <italic>POFUT1</italic> and <italic>POGLUT1</italic>. A previously reported heterozygous nonsense mutation was identified in <italic>POGLUT1</italic>, p.Arg218*; c.652C&gt;T, and confirmed by Sanger sequencing. The mutation was identified in her affected son but not in two unaffected daughters.</p>
    <fig fig-type="Figure" xml:lang="en" id="bjd14914-fig-0001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Clinical findings. (a, b) Reticulate hyperpigmented scaling plaques on the proximal legs of the proband of family 1. (c) Light microscopy of three punch biopsies from the proband of family 1 revealed similar findings of filiform digitate downgrowth of the epidermal rete ridges, presence of small horn cysts, epidermal acanthosis, hypergranulosis, and hyperkeratosis with parakeratosis and suprabasilar acantholysis. (d) Small redâbrown macules and crusted papules widely distributed over the trunk, neck, back, abdomen and limbs of the proband of family 2. The large body folds, hands and feet, and face were spared. (e) The father of the proband of family 2 had similar clinical features, limited to the neck region without involvement of the large flexures. (f) Light microscopy shows some apical acantholysis and parakeratosis with a moderate dermal inflammatory infiltrate. (gâj) The proband of family 3 with multiple small (approximately 5âmmâdiameter) redâbrown scaly papules, present predominantly on the legs but also on the forearms with some postinflammatory change from previous lesions. (k) Light microscopy from the proband of family 3, a mediumâpower view showing elongation of the rete ridge and modest inflammatory infiltrate. (l) A mediumâpower view of a second biopsy from the right anterior thigh. There is an intraepidermal vesicle, as a result of acantholysis of the keratinocytes, some of which show dyskeratosis. Note the elongation of the rete ridges immediately below the vesicle.</p>
      </caption>
      <graphic id="nlm-graphic-1" xlink:href="BJD-176-270-g001"/>
    </fig>
    <p>A second family with GGD/DDD, present in two generations, was also negative for <italic>KRT5</italic> mutation. The proband was a 40âyearâold man who progressively developed, starting from adolescence, small redâbrown macular and papular crusted lesions (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>d). His father had similar clinical features (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>e). Light microscopy showed filiform digitate downgrowth of epidermal rete ridges, presence of small horn cysts, apical acantholysis and parakeratosis with a moderate dermal inflammatory infiltrate (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>f). <italic>POFUT1</italic> and <italic>POGLUT1</italic> were screened by Sanger sequencing (Appendix S1). A previously unreported heterozygous missense mutation was identified in <italic>POGLUT1</italic>, p.Gly170Glu; c.509G&gt;A, in the affected father and affected son, but not in the unaffected mother or unaffected brother (Fig. <xref rid="bjd14914-fig-0002" ref-type="fig">2</xref>a, b). p.Gly170 is highly conserved in the encoded enzyme across species. <italic>In silico</italic> prediction tools, MutationTaster (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/">http://www.mutationtaster.org/</ext-link>) and PolyPhenâ2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), predict this to be a diseaseâcausing variant. It is not in the dbSNP (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>), NHLBI Exome Variant Server (<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>) or ExAC (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>) databases. No mutations were identified in <italic>POFUT1</italic>.</p>
    <fig fig-type="Figure" xml:lang="en" id="bjd14914-fig-0002" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Mutation analysis and protein modelling. (a) Wildâtype <italic><styled-content style="fixed-case">POGLUT</styled-content>1</italic> sequence of exon 5 showing nucleotides c.502â516. (b) Equivalent region as in (a) from the proband of family 2, showing the heterozygous mutation c.509G&gt;A leading to missense mutation p.Gly170Glu. (c) Wildâtype <italic><styled-content style="fixed-case">POGLUT</styled-content>1</italic> sequence showing nucleotides c.850â864 of exon 9. (d) Equivalent region as in (c) from the proband of family 3, showing the heterozygous mutation c.857G&gt;A resulting in missense mutation p.Cys286Tyr. (e) The protein model of human <styled-content style="fixed-case">POGLUT</styled-content>1. The enzyme structure is shown in cartoon format with cylinders (cyan) to represent Î±âhelices, and arrows (purple) Î²âstrands that are linked by coils (brown). The residues Gly170, Cys263 and Cys286 are depicted in <styled-content style="fixed-case">CPK</styled-content> representation coloured N blue, S yellow, O red and C green. The <italic>N</italic>âterminal domain consists of residues 1â180. The modelling predicts that each missense mutation, p.Gly170Glu and p.Cys286Tyr, would compromise enzyme activity due to a reduction in stability of the protein fold near the active site.</p>
      </caption>
      <graphic id="nlm-graphic-3" xlink:href="BJD-176-270-g002"/>
    </fig>
    <p>A 52âyearâold woman, in family 3, presented at age 50 years with a 10âyear history of multiple, sometimes itchy, small redâbrown scaly lesions. These started on her legs then spread onto her forearms with a few lesions on her trunk (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>gâj). Her mother had similar lesions. Light microscopy of different skin biopsies variably showed focal hyperkeratosis, focal parakeratosis, acantholysis and elongation of rete ridges with a mild patchy chronic inflammatory infiltrate in the upper dermis (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>k). One biopsy showed acantholysis, (Fig. <xref rid="bjd14914-fig-0001" ref-type="fig">1</xref>l). Screening of <italic>KRT5</italic> and <italic>POFUT1</italic> did not yield any mutations. A heterozygous missense mutation was identified in <italic>POGLUT1</italic>, p.Cys286Tyr; c.857G&gt;A, in both affected individuals (Fig. <xref rid="bjd14914-fig-0002" ref-type="fig">2</xref>c, d). PolyPhenâ2 and MutationTaster predict this previously unreported variant as disease causing; it is not in the dbSNP, NHLBI Exome Variant Server or ExAC databases. p.Cys286 is highly conserved across a number of species.</p>
    <p>Mutations in <italic>POGLUT1</italic> were reported by Basmanav <italic>et al</italic>.<xref rid="bjd14914-bib-0008" ref-type="ref">8</xref> in 13 unrelated individuals. The majority were nonsense mutations, but there were also a spliceâsite and a missense mutation. We identified one previously reported nonsense mutation, p.Arg218*, and two previously unreported missense mutations, p.Gly170Glu and p.Cys286Tyr. The p.Arg218* mutation results in a truncated form of POGLUT1 that lacks part of the substrateâbinding site required for highâaffinity binding of UDPâglucose.<xref rid="bjd14914-bib-0008" ref-type="ref">8</xref>
</p>
    <p>Using homology modelling, we investigated the effects of the two missense mutations (Fig. <xref rid="bjd14914-fig-0002" ref-type="fig">2</xref>e). Gly170 is on a short helical segment with <italic>C</italic>âalpha hydrogens directed into a hydrophobic pocket that likely stabilizes a subdomain, part of the <italic>N</italic>âterminal domain. This pocket is about 15 Ã distant from the site of catalysis. A mutation to glutamate places a polar and acidic side chain into this hydrophobic environment. The result would be potentially destabilizing electrostatic interactions and steric clashes with Val137, Tyr161 and Ile176. Cys286 is in the <italic>C</italic>âterminal domain, close to Cys263. The model strongly suggests that a disulfide bond would be formed by these two residues. Mutation of Cys286 to tyrosine would remove the highly stabilizing disulfide bond that holds together distinct elements of secondary structure, and then, depending on which sideâchain rotamers were adopted, to clash with Phe278, His282, Leu283, Val260 and Ser288, which form part of the hydrophobic core of the <italic>C</italic>âterminal domain. Again, the consequence would be to destabilize the protein fold at a position about 15 Ã from the site of catalysis. These models predict that each missense mutation, p.Gly170Glu and p.Cys286Tyr, would compromise enzyme activity due to a reduction in stability of the protein fold near the active site.</p>
    <p>POGLUT1 adds <italic>O</italic>âlinked glucose to serine residues in epidermal growth factorâlike repeats of Notch receptors, and is an essential regulator of Notch signalling. Loss of Notch1 and Notch2 in mice results in abnormal pigmentation; these and other studies suggest that mutations in <italic>POGLUT1</italic> resulting in aberrations in Notch signalling would lead to abnormal pigmentation and keratinocyte morphology.<xref rid="bjd14914-bib-0009" ref-type="ref">9</xref>, <xref rid="bjd14914-bib-0010" ref-type="ref">10</xref>
</p>
    <p>Differences were noted between our cases. In family 2, lesions were widely scattered over the entire trunk and limbs (son) and on the neck and upper trunk region (father), rather than in a reticulated pattern. Similarly, in family 3 there was no reticulate rash compared with that of family 1. With only a small number of cases reported it is difficult to draw any genotypeâphenotype correlation.</p>
    <p>These findings expand the spectrum of mutations in <italic>POGLUT1</italic> and confirm <italic>POGLUT1</italic> as the third candidate gene, along with <italic>KRT5</italic> and <italic>POFUT1</italic>, to consider in diagnosis of GGD/DDD.</p>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Appendix S1.</bold> Supplementary methods.</p>
        </caption>
        <media xlink:href="BJD-176-270-s001.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data">
        <caption>
          <p>
<bold>Table S1. </bold>
<italic>POGLUT1</italic> primers for polymerase chain reaction and sequencing.</p>
        </caption>
        <media xlink:href="BJD-176-270-s002.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="bjd14914-sec-0002">
      <title>Acknowledgments</title>
      <p>We thank all of the patients and families involved in this study.</p>
    </ack>
    <ref-list content-type="cited-references" id="bjd14914-bibl-0001">
      <title>References</title>
      <ref id="bjd14914-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0001">
<string-name>
<surname>Muller</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Tremezaygues</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>PfÃ¶hler</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Vogt</surname>
<given-names>T</given-names>
</string-name>. <article-title>The spectrum of reticulate pigment disorders of the skin revisited</article-title>. <source>Eur J Dermatol</source>
<year>2012</year>; <volume>22</volume>:<fpage>596</fpage>â<lpage>604</lpage>.<pub-id pub-id-type="pmid">23018017</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0002">
<string-name>
<surname>Hanneken</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>RÃ¼tten</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pasternack</surname>
<given-names>SM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Systematic mutation screening of KRT5 supports the hypothesis that GalliâGalli disease is a variant of DowlingâDegos disease</article-title>. <source>Br J Dermatol</source>
<year>2010</year>; <volume>163</volume>:<fpage>197</fpage>â<lpage>200</lpage>.<pub-id pub-id-type="pmid">20222933</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0003">
<string-name>
<surname>Schmieder</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pasternack</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Krahl</surname>
<given-names>D</given-names>
</string-name>
<italic>et al</italic>
<article-title>GalliâGalli disease is an acantholytic variant of DowlingâDegos disease: additional genetic evidence in a German family</article-title>. <source>J Am Acad Dermatol</source>
<year>2012</year>; <volume>66</volume>:<fpage>e250</fpage>â<lpage>1</lpage>.<pub-id pub-id-type="pmid">22583733</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0004">
<string-name>
<surname>Betz</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Planko</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Eigelshoven</surname>
<given-names>S</given-names>
</string-name>
<italic>et al</italic>
<article-title>Lossâofâfunction mutations in the keratin 5 gene lead to DowlingâDegos disease</article-title>. <source>Am J Hum Genet</source>
<year>2006</year>; <volume>78</volume>:<fpage>510</fpage>â<lpage>19</lpage>.<pub-id pub-id-type="pmid">16465624</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0005">
<string-name>
<surname>Reisenauer</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Wordingham</surname>
<given-names>SV</given-names>
</string-name>, <string-name>
<surname>York</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Heterozygous frameshift mutation in keratin 5 in a family with GalliâGalli disease</article-title>. <source>Br J Dermatol</source>
<year>2014</year>; <volume>170</volume>:<fpage>1362</fpage>â<lpage>5</lpage>.<pub-id pub-id-type="pmid">24372084</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0006">
<string-name>
<surname>Basmanav</surname>
<given-names>FB</given-names>
</string-name>, <string-name>
<surname>Fritz</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lestringant</surname>
<given-names>GG</given-names>
</string-name>
<italic>et al</italic>
<article-title>Pathogenicity of POFUT1 in DowlingâDegos disease: additional mutations and clinical overlap with reticulate acropigmentation of Kitamura</article-title>. <source>J Invest Dermatol</source>
<year>2015</year>; <volume>135</volume>:<fpage>615</fpage>â<lpage>18</lpage>.<pub-id pub-id-type="pmid">25229252</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0007">
<string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>J</given-names>
</string-name>
<italic>et al</italic>
<article-title>Mutations in POFUT1, encoding protein Oâfucosyltransferase 1, cause generalized DowlingâDegos disease</article-title>. <source>Am J Hum Genet</source>
<year>2013</year>; <volume>92</volume>:<fpage>895</fpage>â<lpage>903</lpage>.<pub-id pub-id-type="pmid">23684010</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0008">
<string-name>
<surname>Basmanav</surname>
<given-names>FB</given-names>
</string-name>, <string-name>
<surname>Oprisoreanu</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Pasternack</surname>
<given-names>SM</given-names>
</string-name>
<italic>et al</italic>
<article-title>Mutations in POGLUT1, encoding protein Oâglucosyltransferase 1, cause autosomalâdominant DowlingâDegos disease</article-title>. <source>Am J Hum Genet</source>
<year>2014</year>; <volume>94</volume>:<fpage>135</fpage>â<lpage>43</lpage>.<pub-id pub-id-type="pmid">24387993</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0009">
<string-name>
<surname>AubinâHouzelstein</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>DjianâZaouche</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bernex</surname>
<given-names>F</given-names>
</string-name>
<italic>et al</italic>
<article-title>Melanoblasts' proper location and timed differentiation depend on Notch/RBPâJ signaling in postnatal hair follicles</article-title>. <source>J Invest Dermatol</source>
<year>2008</year>; <volume>128</volume>:<fpage>2686</fpage>â<lpage>95</lpage>.<pub-id pub-id-type="pmid">18463680</pub-id></mixed-citation>
      </ref>
      <ref id="bjd14914-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="bjd14914-cit-0010">
<string-name>
<surname>Kumano</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Masuda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sata</surname>
<given-names>M</given-names>
</string-name>
<italic>et al</italic>
<article-title>Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis</article-title>. <source>Pigment Cell Melanoma Res</source>
<year>2008</year>; <volume>21</volume>:<fpage>70</fpage>â<lpage>8</lpage>.<pub-id pub-id-type="pmid">18353145</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>